Dr. Cantalino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1648 Huntingdon Pike
Meadowbrook, PA 19046
Summary
- Jonathan Cantalino, DO, is a Radiation Oncologist based in Meadowbrook, PA, currently practicing at Holy Redeemer Hospital. He completed his medical education at Philadelphia College of Osteopathic Medicine in 2019 and his residency in Radiation Oncology at MedStar Health/Georgetown University Hospital from 2020 to 2024. He holds a B.A. in Molecular, Cellular, and Developmental Biology from Yale University. Dr. Cantalino has authored several publications on topics including pancreatic cancer, brain tumors, prostate cancer, and penile cancer, with some works cited by other publications.
Education & Training
MedStar Health/Georgetown University HospitalResidency, Radiation Oncology, 2020 - 2024
Crozer-Chester Medical CenterInternship, Transitional Year, 2019 - 2020
Philadelphia College of Osteopathic MedicineClass of 2019- Yale UniversityB.A., Molecular, Cellular, and Developmental Biology, 2006 - 2010
Certifications & Licensure
PA State License 2024 - 2026
DC State License 2020 - 2024
VA State License 2022 - 2023
Publications & Presentations
PubMed
- Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanc...Nicole Libbey, Lindsey Gallagher, Jonathan Cantalino, Benjamin A Weinberg, Marcus S Noel
Journal of Gastrointestinal Cancer. 2024-06-01 - Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate Cancer.Tamir Sholklapper, Michael Creswell, Jonathan Cantalino, Michael Markel, Alan Zwart
The Journal of Sexual Medicine. 2022-05-01 - 2 citationsSalvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysis.Kyle C Wu, Jonathan M Cantalino, Edward C Dee, Liangge Hsu, Thomas C Harris
Neuro-Oncology Advances. 2022-04-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
